fda warning letter compounding pharmacy bpc-157 cites companies for CGMP violations, telehealth firms for illegally marketing GLP-1 drugs 2-bottles Murrieta – Medical Weight Size:1000 mcg/ml - 30 ml x 2

fda warning letter compounding pharmacy bpc-157 cites companies for CGMP violations, telehealth firms for illegally marketing GLP-1 drugs 2-bottles Murrieta – Medical Weight Size:1000 mcg/ml - 30 ml x 2

Murrieta – Medical Weight Controls

Toxic solvent residues DMF (dimethylformamide) Known liver toxin Associated with reproductive toxicity Must be removed to extremely low limits in GMP drugs DCM (dichloromethane / methylene chloride) Probable human carcinogen Central nervous system depressant Dangerous even in small amounts if injected TFA (trifluoroacetic acid) Corrosive Can remain in peptides as unmeasured TFA salt Pharmaceutical products often convert TFA salts to safer counterions Without validated HPLC, mass spectrometry, and residual solvent testing, patients may be injected with harmful chemical contaminants

2-bottles

Size:1000 mcg/ml - 30 ml x 2

Low LDL cholesterol and brain health: debunking the myth of cognitive risk [33:45]